Management of Gestational Weight Gain by Family Physicians: Seeking Congruence With Guidelines

Brief Summary

Official Title: “MANAGEMENT OF GESTATIONAL WEIGHT GAIN BY FAMILY PHYSICIANS: SEEKING CONGRUENCE WITH GUIDELINES”

Background The Institute of Medicine (IOM) published guidelines in 2009 for optimal gestational weight gain (GWG) during pregnancy. These guidelines include trajectories for optimal GWG, based on a woman's pre-pregnancy body mass index (BMI), to be used throughout the duration of a pregnancy. Although there is a significant association between the total GWG recommended by these guidelines and maternal and perinatal outcomes, research has demonstrated that only approximately one-third of pregnant women have total GWG within the recommended amounts. Factors known to influence GWG include maternal age, parity, being in a committed relationship and smoking. In addition, recommendations by primary care providers have been shown to influence actual GWG. Women appreciate advice from their primary care providers, however, despite this, there is evidence that many patients report not being advised at all about GWG by their primary care providers.

Relevance Excess weight gain in pregnancy has been shown to be a modifiable risk factor for excess weight in childhood, thus contributing to the intergenerational cycle of obesity. There is an opportunity to interfere with this cycle during the peri-pregnancy period, as women's motivation to engage in behaviour change is elevated and contact with their primary care providers is frequent.

Research Question and Hypothesis What impact does training family physicians to regularly refer to the IOM trajectories and provide feedback about GWG ("training in the use of IOM charts") during routine prenatal visits, compared to usual care, have on congruence of total GWG with IOM guidelines? Null Hypothesis: there is no difference in the congruence of total GWG with IOM guidelines between women whose family physicians were assigned to training in the use of the IOM charts and those whose family physicians were assigned to usual care.

Objectives

The following are the objectives for this study:

1. To compare the congruence of total GWG with IOM guidelines between women whose family physicians were assigned to training in the use of IOM trajectories and those whose family physicians were assigned to usual care.

2. To explore the relationship between other independent variables (maternal age, parity, committed relationship and smoking) and congruence of total GWG with IOM guidelines, for women whose family physicians were assigned to training in the use of IOM trajectories and for those whose family physicians were assigned to usual care.

  • Study Type: Interventional
  • Study Design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Prevention
  • Study Primary Completion Date: August 2015

Interventions Used in this Clinical Trial

  • Behavioral: Training in the use of IOM charts

Arms, Groups and Cohorts in this Clinical Trial

  • Experimental: Training in the use of IOM charts
    • Training family physicians to regularly refer to the Institute of Medicine guideline trajectories and provide feedback about GWG (“training in the use of IOM charts”) during routine prenatal visits.
  • No Intervention: Usual care
    • Family physicians providing usual prenatal care.

Outcome Measures for this Clinical Trial

Primary Measures

  • Congruence with gestational weight gain guidelines
    • Time Frame: up to 38 weeks after enrolment
      Safety Issue?: No

Criteria for Participation in this Clinical Trial

Inclusion Criteria

  • family physicians who provide prenatal care
  • pregnant women with low risk pregnancy

Exclusion Criteria

  • pregnant women < 18 years old
  • pregnant women with multiple gestation
  • pregnant women with chronic disease
  • pregnant women initially presenting in second trimester or later.

Gender Eligibility for this Clinical Trial: Both

Minimum Age for this Clinical Trial: 18 Years

Maximum Age for this Clinical Trial: N/A

Are Healthy Volunteers Accepted for this Clinical Trial: Accepts Healthy Volunteers

Clinical Trial Investigator Information

  • Lead Sponsor
    • Capital District Health Authority, Canada
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Helena Piccinini-Vallis, MSc MD, Principal Investigator, Department of Family Medicine Dalhousie University
  • Overall Contact(s)
    • Helena Piccinini-Vallis, MSc MD, 902-473-4747, hpiccinini@me.com

Source

Clinical Trials content is provided directly by the US National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of information about a specific clinical trial contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is:
http://clinicaltrialsfeeds.org/clinical-trials/show/NCT01803698